Abstract
The molecular heterogeneity of cancer suggests that simultaneous screening of a sample for different molecular markers is necessary in order to increase accuracy of cancer diagnosis. DNA chip technologies address this problem at the genomic level and provide accessibility to gene expression profiles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbott A: A post-genomic challenge: learning to read patterns of protein synthesis. Nature, 402:715, 1999.
Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D, Naven T, et al: The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis: Preliminary findings. Electrophoresis, 20:689, 1999.
Billed TM, Stults BT: Tryptic mapping of recombinant proteins by matrix-assisted laser/desorption ionization mass spectrometry. Anal Chem, 65:1709, 1993.
Carr SA, Hemling ME, Bean MF, Roberts GD: Integration of mass spectrometry in analytical biotechnology. Anal Chem, 63:2802, 1991.
Carr SA, Annan RS: Overview of Peptide and Protein Analysis by Mass Spectrometry. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current Protocols in Molecular Biology. New York: John Wiley & Sons Inc.; unit 10.21, pp. 10.21.1–10.21.27, 1998.
Clauser KR, Hall SC, Smith DM, Webb JW, Andrewes LE, Tran HM, et al: Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci USA, 92:5072, 1995.
Dogruel D, Williams P, Nelson RW: Rapid tryptic mapping using enzymatically-active mass spectrometer probe tips. Anal Chem, 67:4343, 1995.
Emmert-Buck MR, Bonner RF, Smith PD, Chuagui FR, Zhuang Z, Goldstein SR, et al: Laser capture microdissection. Science, 274:998, 1996.
Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM: Electrospray ionization for the mass spectrometry of large biomolecules. Science, 246:64, 1989.
Grossman HB, Dinney CPN: Markers of bladder cancer: State of the art. Urol Oncol, 5:3, 2000.
Hillenkamp F, Karas M, Beavis RC, Chait BT: Matrix Assisted Laser Desorption Ionization Mass Spectrometry of biopolymers. Anal Chem, 63:1193, 1991.
Hunt DF, Yates JR, Shabanowitzz J, Winston S, Hauer CR: Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci USA, 83:6233, 1986.
Hutchens TW, Yip TT: New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom, 7:576, 1993.
Hutchens TW, Yip TT: Affinity Mass Spectrometry. Protein Sci, 2:92, 1993.
Israeli RS, Powell CT, Corr JG, Fair WR, Heston WDW: Expression of the prostate specific membrane antigen. Cancer Res, 54:1807, 1991.
Jensen ON, Podtelejnikov AV, Mann, M: Identification of the components of simple protein mixtures by high accuracy peptide mass mapping and database searching. Anal Chem, 69:4741, 1997.
Karas M, Bachmann D, Bahr U, Hillenkamp F: Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int J Mass Spectrom Ion Proc, 78:53, 1987.
Karas M, Hillenkamp F: Laser desorption ionization of proteins with molecular mass exceeding 10000 daltons. Anal Chem, 60:2299, 1988.
Kaufmann R, Kirsch D, Spengler B: Sequencing of peptides in a time of flight MS: Evaluation of a post source decay following matrix-assisted laser desorption ionization (MALDI). Int J Mass Spectrom Ion Process, 131:355, 1994.
Kaufmann R: Matrix-assisted laser desorption ionization (MALDI) mass spectrometry: a novel analytical tool in molecular biology and biotechnology. J Biotech, 41:155, 1995.
Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW: Bactericidal domain of lactoferrin: Detection, quantitation and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophy Res Commun, 245:764, 1998.
Machold J, Utkin Y, Kirach D, Kaufmann R, Tsetlin V: Photolabeling reveals the proximity of the a-neurotoxin binding site to the M2 helix of the ion channel in the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA, 92:7282, 1995.
Mann M, Shen S, Fenn JB: Electrospray mass spectrometry. In: Gross ML, editor. Mass Spectrometry in the Biological Sciences. New York: Kluwer Academic Publishers; pp. 145–160, 1992.
Mann M, Wilm M: Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem, 66:4390, 1994.
Mann M, Talbo G: Developments in matrix-assisted laser desorption ionization peptide mass spectrometry. Curr Opin Biotechnol, 7(1): 11, 1996.
Meng CK, Mann M, Fenn JB: Of protons or proteins. Zeitschr F Physik, 10:361, 1988.
Moore WT: Laser Desorption Mass Spectrometry. In: Fields GB, editor. Methods in Enzymology. New York: Academic Press; 289:520–542, 1997.
Nelson RW, McLean MA, Hutchens TW: Quantitative determination of proteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem, 66:1408, 1994.
O’Farrel PH: High-resolution two-dimensional gel electrophoresis of proteins. J Biol Chem, 250:4007, 1975.
Osterling JE: Prostate Specific Antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol, 145:907, 1991.
Patterson SD: From electrophoretically separated proteins to identification: Strategies for sequence and mass analysis. Anal Biochem, 221:1, 1994.
Patterson SD: Matrix-assisted laser desorption/ionization mass spectrometric approaches for the identification of gel-separated proteins in the 5–50pmol range. Electrophoresis, 16:1104, 1995.
Patterson SD: Protein Identification and Characterization by Mass Spectrometry. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current Protocols in Molecular Biology. New York: John Wiley & Sons Inc.; unit 10.22, pp. 10.22.1–10.22.24, 1998.
Paweletz CP, Ornstein DK, Gillespie JW, Hutchens TW, Cole KA, Simone N, et al: A novel proteomic approach to monitor carcinogenic disease progression using surface-enhanced laser desorption ionization spectroscopy (SELDI) of laser capture microdissection (LCM)-derived cells from cancer. Proc Amer Assoc Cancer Res, 40:411 (abs. 2717), 1999.
Rasmussen HH, Orntoft TF, Wolf H, Celis JE: Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol, 155:2113, 1996.
Rossi D, Hoffman KL, Janiczek-Dolphin N, Bockbrader H, Parker TD: Tandem-in-Time Mass Spectrometry as a Quantitative Bioanalytical Tool. Anal Chem, 69:4519, 1997.
Siuzdak G: The emergence of mass spectrometry on biochemical research. Proc Natl Acad Sci USA, 91:11290, 1994.
Thiede B, Wittmann-Liebold B, Biernert M, Krause E: MALDI-MS for C-terminal sequence determination of peptides and proteins degraded by carboxypeptidase Y and P. FEBS Lett, 357: 65, 1995.
Vlahou A, Mendrinos S, Kondylis FI, Schellhammer PF, Lynch Jr, DF, Wright Jr GL: Desorption, Ionization Time of Flight Mass Spectrometry (SELDI-TOF-MS): A novel proteomic approach to identify bladder cancer biomarkers. Proceedings of the AACR-NCI-EORTC International Conference. Clin Cancer Res, 5:38675s (abs 688), 1999.
Vorm O, Roepstorff P: Peptide sequence information derived by partial acid hydrolysis and matrix-assisted laser desorption/ionization mass spectrometry. Biol Mass Spectrom, 23:734, 1994.
Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of human prostate specific antigen. Invest Urol, 17:159, 1979.
Whittal RM, Keller BO, Liang L: Nanoliter chemistry combined with mass spectrometry for peptide mapping of proteins from single mammalian cell lysates. Anal Chem, 70:5344, 1998.
Wilking MR, Sanchez J-C, Gooley AA, Appel RD, Humphrey-Smith I, Hochstrasser DF, et al: Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev, 13:19, 1995.
Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T, et al: Femtomole sequencing of proteins from acrylamide gels by nano-electrospray mass spectrometry. Nature, 379:466, 1996.
Wright Jr. GL, Haley C, Beckett M-L, Schellhammer PF: Expression of prostate specific membrane antigen in normal, benign and malignant prostate tissues. Urol Oncol, 1:18, 1995.
Wright Jr. GL, Cazares LH, Leung S-M, Nasim S, Adam B-L, Yip T-T, et al: ProteinChipâ„¢ surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate cancer and prostatic diseases, in press.
Yip TT, Van de Water J, Greshwin ME, Coppel R., Hutchens TW: Cryptic antigenic determinants on the extracellular pyruvate dehydrogenase complex/mimeotope found in primary biliary cirrhosis. J Biol Chem, 271:32825, 1996.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vlahou, A., Schellhammer, P.F., Wright, G.L. (2003). Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers. In: Atala, A., Slade, D. (eds) Bladder Disease, Part A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8889-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8889-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4707-1
Online ISBN: 978-1-4419-8889-8
eBook Packages: Springer Book Archive